Jack Bourke
Impact in
-
- Antibiotic Use and Resistance
- Pharmacology top 2%
- Drug-Induced Adverse Reactions
Papers in
- Pharmacology 10
- Drug-Induced Adverse Reactions 10
- Oncology 2
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Elizabeth Jane Phillips (4 shared papers)IAN R. JAMES (1 shared paper)Rebecca K. Pavlos (2 shared papers)Natasha E. Holmes (2 shared papers)Abby P. Douglas (2 shared papers)Kyra Chua (2 shared papers)Sara Vogrin (2 shared papers)Cosby A. Stone (2 shared papers)
- Journals
- Australasian Journal of Dermatology (2 papers)Pathology (1 paper)International Journal of Infectious Diseases (1 paper)JAMA Internal Medicine (1 paper)BMJ Open (1 paper)
- Partner nations
- AustraliaUnited States
In The Last Decade
Jack Bourke
15 papers receiving 644 citations
Jack Bourke's Hit Papers
Peers
Comparison fields: 5 of 52
- Applied Microbiology and Biotechnology 111
- Pharmacology 498
- Toxicology 67
- Immunology and Allergy 27
- Pharmacology 24
Countries citing papers authored by Jack Bourke
This map shows the geographic impact of Jack Bourke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Bourke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Bourke more than expected).
Fields of papers citing papers by Jack Bourke
This network shows the impact of papers produced by Jack Bourke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Bourke. The network helps show where Jack Bourke may publish in the future.
Co-authors
The 25 scholars most cited alongside Jack Bourke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Development and Validation of a Penicillin Allergy Clinical Decision Rule Hit paper breakdown → | 2020 | 246 |
| 2 | 2019 | 144 | |
| 3 | 2015 | 135 | |
| 4 | Testing for drug hypersensitivity syndromes. | 2013 | 62 |
| 5 | 2016 | 28 | |
| 6 | 2020 | 11 | |
| 7 | 2022 | 10 | |
| 8 | 2003 | 6 | |
| 9 | 2017 | 4 | |
| 10 | 2022 | 3 | |
| 11 | 2022 | 3 | |
| 12 | Penicillin de-labelling in tertiary clinics: Safe and efficacious but incomplete effectiveness | 2012 | 2 |
| 13 | Safely preventing errors and complications due to inappropriate allergy labelling - the special a study | 2019 | 1 |
| 14 | 2025 | 1 | |
| 15 | 2025 | 1 |
About Jack Bourke
Jack Bourke is a scholar working on Pharmacology, Oncology, Emergency Medical Services, Dermatology and Safety, Risk, Reliability and Quality, having authored 15 papers that have together received 657 indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (10 papers), Cancer Immunotherapy and Biomarkers (2 papers), Traffic and Road Safety (1 paper), Clinical Laboratory Practices and Quality Control (1 paper), Patient Safety and Medication Errors (1 paper), Dermatological and COVID-19 studies (1 paper), Substance Abuse Treatment and Outcomes (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (111 citations), Pharmacology (498 citations), Toxicology (67 citations), Immunology and Allergy (27 citations) and Pharmacology (24 citations). Jack Bourke has collaborated with scholars based in Australia and United States. Frequent co-authors include Elizabeth Jane Phillips, IAN R. JAMES, Rebecca K. Pavlos, Natasha E. Holmes, Abby P. Douglas, Kyra Chua, Sara Vogrin, Cosby A. Stone, Jason Anthony Trubiano and James J Yun. Their work appears in journals such as Australasian Journal of Dermatology, Pathology, International Journal of Infectious Diseases, JAMA Internal Medicine and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.